Ardent Health (NYSE:ARDT) Stock Price Expected to Rise, Truist Financial Analyst Says

Key Points

• Truist Financial raised Ardent Health’s price target to $13 from $12 and maintained a “buy” rating, implying approximately 16% upside from the stock’s $11.21 price.
• Analyst sentiment is mixed: seven analysts rate Ardent Health a buy, five a hold and two a sell, resulting in a consensus “hold” rating and average price target of $13.54.
• Ardent Health’s latest quarterly EPS of $0.12 missed estimates of $0.18, although revenue of $1.62 billion exceeded expectations of $1.59 billion; management issued fiscal 2026 EPS guidance of $0.78–$1.15.

Ardent Health (NYSE:ARDT - Get Free Report) had its target price upped by Truist Financial from $12.00 to $13.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Truist Financial's price target indicates a potential upside of 16.01% from the company's current price.

Several other equities analysts also recently commented on ARDT. UBS Group increased their price target on Ardent Health from $13.00 to $13.50 and gave the company a "buy" rating in a report on Thursday, May 7th. Weiss Ratings reiterated a "sell (d+)" rating on shares of Ardent Health in a research note on Friday, June 12th. Wall Street Zen downgraded shares of Ardent Health from a "buy" rating to a "hold" rating in a research note on Sunday, July 12th. Royal Bank Of Canada decreased their target price on Ardent Health from $13.00 to $12.00 and set an "outperform" rating on the stock in a research report on Thursday, July 9th. Finally, The Goldman Sachs Group reaffirmed a "neutral" rating and issued a $13.00 target price on shares of Ardent Health in a research report on Thursday. Seven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $13.54.

Ardent Health Price Performance

ARDT traded up $0.05 during trading on Thursday, reaching $11.21. 150,031 shares of the stock were exchanged, compared to its average volume of 463,287. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. Ardent Health has a 1 year low of $7.71 and a 1 year high of $15.48. The business's 50 day moving average price is $9.89 and its two-hundred day moving average price is $9.46. The company has a market capitalization of $1.61 billion, a price-to-earnings ratio of 20.43, a P/E/G ratio of 2.53 and a beta of 0.70.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a return on equity of 10.45% and a net margin of 1.22%.Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, equities research analysts anticipate that Ardent Health will post 1.06 earnings per share for the current year.

Insider Buying and Selling

In other news, CFO Alfred Lumsdaine bought 10,000 shares of the stock in a transaction on Friday, June 5th. The stock was acquired at an average price of $8.81 per share, with a total value of $88,100.00. Following the acquisition, the chief financial officer directly owned 329,183 shares in the company, valued at approximately $2,900,102.23. This trade represents a 3.13% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd boosted its holdings in Ardent Health by 1,177.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company's stock worth $25,000 after acquiring an additional 2,638 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of Ardent Health in the third quarter valued at $61,000. New York State Common Retirement Fund lifted its position in Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company's stock worth $85,000 after buying an additional 3,400 shares during the last quarter. Monetary Solutions Ltd bought a new stake in Ardent Health during the 4th quarter valued at $79,000. Finally, Abel Hall LLC purchased a new position in shares of Ardent Health during the first quarter valued at about $87,000.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company's integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source